Crossmark

Simple determination and quantification of tofacitinib, a JAK inhibitor, in rat plasma, urine and tissue homogenates by HPLC and its application to a pharmacokinetic study

Crossref DOI link: https://doi.org/10.1007/s40005-020-00490-z

Published Online: 2020-05-07

Published Print: 2020-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Ji Eun

Park, Mun Young

Kim, So Hee
Funding

Funding for this research was provided by:

Korea Health Industry Development Institute (HI16C0992)
License Information

Text and Data Mining valid from 2020-05-07

Version of Record valid from 2020-05-07
More Information

Article History

Received: 20 December 2019

Accepted: 28 April 2020

First Online: 7 May 2020

Compliance with ethical standards

:

: All authors (Kim JE, Park MY and Kim SH) declare that they have no conflict of interest.

: All experimental procedures and protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the Laboratory Animal Research Center of Ajou University Medical Center (IACUC No. 2017-0074, 2018) (Suwon, Republic of Korea).

Document is current

Any future updates will be listed below